Modulation of Deubiquitinase Family Members The present invention relates to the therapeutic treatment of conditions by modulating members of the deubiquitinase family, and also to assays for identifying substances which may be useful in such treatments, as well as to the treatment of cylindromatosis and more generally to the modulation of other conditions associated with activation of the transcription factor NF-KB, such as inflammation.
申请公布号
WO2004064711(A2)
申请公布日期
2004.08.05
申请号
WO2004EP00408
申请日期
2004.01.16
申请人
VERENIGING HET NEDERLANDS KANKER INSTITUUT;BERNARDS, RENE;BRUMMELKAMP, THIJN R.;DIRAC, ANNETTE M.;NIJMAN, SEBASTIAN M.
发明人
BERNARDS, RENE;BRUMMELKAMP, THIJN R.;DIRAC, ANNETTE M.;NIJMAN, SEBASTIAN M.
